Human heart organoid (ORG HEART)
A 3D in vitro cardiac organoid model that recapitulates key
aspects of human heart development
-
01
Key Characteristics of ORG HEART- Self-Organized 3D Cardiac Organoids without Exogenous ECM
- Multicellular Cardiac Organoids Including Cardiomyocytes, Endothelial Cells, and Fibroblasts
- Cardiac Development in Vitro with Trabeculation and Compact Myocardium Formation
- Convenient Disease Modeling
-
02
Toxicity and Efficacy Evaluation of Innovative Drugs
ORG HEART supports integrated assessment of drug efficacy and cardiotoxicity.
Real-time monitoring of calcium signaling and contractile responses enables quantitative functional analysis.- Non-Invasive Quality Control and Longitudinal Monitoring
- Integrated Multi-Parameter Analysis
- Multimodal Functional Analysis
- Customized Evaluation Services
-
03
Development of next-generation cardiac regenerative therapiesWe investigate vascularized cardiac organoids in myocardial experimental model.
Our research measures cardiomyocyte survival, cardiac function recovery, and improvements in tissue perfusion and engraftment.- Cardiomyocyte Replacement and Integration
- Cardiac Functional Recovery
- Neovascularization for Cardiac Maturation and Myocardial Repair